Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion type Assertion NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_head.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion description "[Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_provenance.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion evidence source_evidence_literature NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_provenance.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion SIO_000772 10353729 NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_provenance.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion wasDerivedFrom befree-20140225 NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_provenance.
- NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_assertion wasGeneratedBy ECO_0000203 NP505151.RAGYIVI0xtlHknf0Qm7x0L-eAM9sLTvM0QWlr9M9pH8ag130_provenance.